相似文献
1
Drug reaction eosinophilia and systemic symptoms: Clinical phenotypic patterns according to causative drug.
J Am Acad Dermatol. 2024 Jun;90(6):1240-1242. doi: 10.1016/j.jaad.2023.05.067. Epub 2023 Jun 3.
2
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
J Am Acad Dermatol. 2024 May;90(5):885-908. doi: 10.1016/j.jaad.2023.02.072. Epub 2023 Jul 27.
3
Hemodialysis treatment of vancomycin-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome in a patient undergoing peritoneal dialysis.
CEN Case Rep. 2024 Oct;13(5):339-345. doi: 10.1007/s13730-023-00847-x. Epub 2024 Feb 10.
4
Flares in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: a retrospective study.
Arch Dermatol Res. 2023 Dec 1;316(1):8. doi: 10.1007/s00403-023-02741-z.
5
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
J Am Acad Dermatol. 2024 May;90(5):911-926. doi: 10.1016/j.jaad.2023.02.073. Epub 2023 Jul 28.
6
Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
J Am Acad Dermatol. 2023 May;88(5):1142-1145. doi: 10.1016/j.jaad.2022.11.034. Epub 2022 Nov 25.
7
Vancomycin-associated drug-induced hypersensitivity syndrome.
J Am Acad Dermatol. 2019 Jul;81(1):123-128. doi: 10.1016/j.jaad.2019.02.002. Epub 2019 Feb 6.
8
Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.
J Am Acad Dermatol. 2024 Aug;91(2):370-373. doi: 10.1016/j.jaad.2024.04.036. Epub 2024 Apr 26.
9
Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole.
Contact Dermatitis. 2018 Aug;79(2):105-106. doi: 10.1111/cod.13002. Epub 2018 Apr 10.
10
Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.
JAMA Dermatol. 2022 Dec 1;158(12):1449-1453. doi: 10.1001/jamadermatol.2022.3541.
引用本文的文献
1
Vancomycin Drug Reaction with Eosinophilia and Systemic Symptoms: Meta-Analysis and Pharmacovigilance Study.
J Clin Med. 2025 Jan 31;14(3):930. doi: 10.3390/jcm14030930.
2
Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.
J Am Acad Dermatol. 2024 Aug;91(2):370-373. doi: 10.1016/j.jaad.2024.04.036. Epub 2024 Apr 26.
本文引用的文献
1
A Shorter Time to Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Redefining Beta-Lactam-Associated DRESS.
Clin Infect Dis. 2023 Feb 18;76(4):772-774. doi: 10.1093/cid/ciac798.
2
DRESS characteristics according to the causative medication.
Eur J Clin Pharmacol. 2022 Sep;78(9):1503-1510. doi: 10.1007/s00228-022-03353-8. Epub 2022 Jun 20.
3
Updates and Insights in the Diagnosis and Management of DRESS Syndrome.
Curr Dermatol Rep. 2021;10(4):192-204. doi: 10.1007/s13671-021-00348-z. Epub 2021 Nov 9.
4
Variation of clinical manifestations according to culprit drugs in DRESS syndrome.
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):840-848. doi: 10.1002/pds.4774. Epub 2019 May 1.
5
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.
J Allergy Clin Immunol Pract. 2019 Feb;7(2):633-640. doi: 10.1016/j.jaip.2018.08.013. Epub 2018 Aug 31.
Zotero 插件